No Data
Market Chatter: Novo Holdings to Win EU Approval for $16.5 Billion Catalent Takeover
The EU may unconditionally approve novo-nordisk a/s's acquisition of catalent.
The European Commission may unconditionally approve novo-nordisk a/s's parent company, Novo Holdings, to acquire the usa contract pharmaceutical company catalent for 16.5 billion USD.
EU Antitrust Regulators Expected to Approve Novo Holdings' $16.5B Acquisition of Catalent Without Conditions
Catalent Stock Soars to 52-week High, Hits $61.32
Morgan Stanley Lists Hedge Funds' Largest Q3 Ownership Increases in Russell 1000 Stocks
US Manufacturing Index Rises To 43, Highest Since 2020